Find Ceftaroline Fosamil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Canada

0

Australia

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

3RELATED EXCIPIENT COMPANIES

3EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Tak-599, Schembl1464044, Gtpl10899, Q409712, (6r,7r)-7-((z)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Molecular Formula
C22H21N8O8PS4
Molecular Weight
684.7  g/mol
InChI Key
ZCCUWMICIWSJIX-XHNDKCDBSA-N

Ceftaroline Fosamil
1 2D Structure

Ceftaroline Fosamil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(6R,7R)-7-[[(2E)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
2.1.2 InChI
InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/b26-13+/t14-,19-/m1/s1
2.1.3 InChI Key
ZCCUWMICIWSJIX-XHNDKCDBSA-N
2.1.4 Canonical SMILES
CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-]
2.1.5 Isomeric SMILES
CCO/N=C(\C1=NSC(=N1)NP(=O)(O)O)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Ceftaroline Fosamil

2. Ppi-0903

3. Ppi0903

4. Tak-599

5. Tak599

6. Teflaro

2.2.2 Depositor-Supplied Synonyms

1. Tak-599

2. Schembl1464044

3. Gtpl10899

4. Q409712

5. (6r,7r)-7-((z)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

2.3 Create Date
2014-04-11
3 Chemical and Physical Properties
Molecular Weight 684.7 g/mol
Molecular Formula C22H21N8O8PS4
XLogP32.3
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count17
Rotatable Bond Count10
Exact Mass684.01028135 g/mol
Monoisotopic Mass684.01028135 g/mol
Topological Polar Surface Area330 Ų
Heavy Atom Count43
Formal Charge0
Complexity1210
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


4.2 ATC Code

J01DI02

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


USDMF

read-more
read-moreread-more

01

Acs Dobfar Spa

Italy

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

01

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 23167

Submission : 2009-10-09

Status : Active

Type : II

blank

02

Vietnam Medi-Pharm Expo
Not Confirmed

02

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-08-27

Pay. Date : 2014-05-16

DMF Number : 28245

Submission : 2014-06-25

Status : Active

Type : II

blank

03

Vietnam Medi-Pharm Expo
Not Confirmed

03

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40900

Submission : 2024-11-29

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Ceftaroline Fosamil

About the Company : Akums Lifescience Ltd. is a research-based, vertically integrated company specializing in the development, manufacturing and sale of APIs and intermediates. Akums has established i...

Akums Lifescience Ltd. is a research-based, vertically integrated company specializing in the development, manufacturing and sale of APIs and intermediates. Akums has established itself as a leading generic medicine manufacturing company from India, with clients in over 51 countries. It has a facility dedicated to custom research and synthesis. Akums’ manufacturing facilities are spread across three locations in two Indian states. Its stringent policies and procedures ensure that that all regulatory requirements, environmental standards, and technological trends are met. Akums is EU-GMP, KFDA, WHO-GMP and PMDA certified.
blank

02

Gencor

U.S.A
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

Gencor

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Ceftaroline Fosamil

About the Company : Our herbal ingredients have been clinically studied and shown effective in both animal and human clinical trials. Many of our clinical trials are peer-reviewed, double-blind contro...

Our herbal ingredients have been clinically studied and shown effective in both animal and human clinical trials. Many of our clinical trials are peer-reviewed, double-blind controlled trials with impressive results. In addition to formal research tests, our ingredients go through rigorous scientific analysis with our state-of-the-art testing equipment under GLP-certified conditions. Gencor botanicals are grown under the close supervision of our technical team and according to strict quality-assurance processes. For instance, our herbs are always dried in the shade, so they maintain their phytochemical content.
blank

03

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Ceftaroline Fosamil

About the Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include c...

Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include customized R&D as well as the production of small molecule pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs) for both international and domestic pharmaceutical firms. Our capabilities span from laboratory-scale kilograms to commercial ton-scale production. Additionally, we are committed to independent research and development, as well as the production and sales of high-end pharmaceutical intermediates and API products.
blank

04

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Ceftaroline Fosamil

About the Company : Suzhou Ryway Biotech Co., Ltd. is located in Suzhou of Jiangsu Provice. It is a comprehensive enterprise integrated of product research, manufacturing, marketing and service. There...

Suzhou Ryway Biotech Co., Ltd. is located in Suzhou of Jiangsu Provice. It is a comprehensive enterprise integrated of product research, manufacturing, marketing and service. There is strong technical strength, advanced testing method, precision manufacturing equipment. Main products are medical intermediate and fine chemicals. The product is popular among domestic users. In addition, they have been exported to Southeast Asia, Europe and America regions. Our operation tenet is “quality first, customer first”. We constantly improve our market competitiveness. We expect to cooperate with wide colleagues and create brilliance together.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Cefazolin is a antibiotic drug, which is currently being evaluated in Phase IV clinical studies for the treatment of staphylococcal infections.


Lead Product(s): Cefazolin,Nafcillin,Ertapenem,Vancomycin Hydrochloride,Daptomycin,Ceftaroline Fosamil

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Antibiotic

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 29, 2026

blank

01

Intermountain Health

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Intermountain Health

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Cefazolin is a antibiotic drug, which is currently being evaluated in Phase IV clinical studies for the treatment of staphylococcal infections.

Product Name : Undisclosed

Product Type : Antibiotic

Upfront Cash : Inapplicable

January 29, 2026

blank

Details:

Ceftaroline is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Fractures, Open.


Lead Product(s): Ceftaroline Fosamil,Inapplicable

Therapeutic Area: Orthopedics/Orthopedic Surgery Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Olayemi Osiyemi MD

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 18, 2016

blank

02

Vietnam Medi-Pharm Expo
Not Confirmed
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Ceftaroline is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Fractures, Open.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 18, 2016

blank
  • Development Update

Details:

Ceftriaxone is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Community-Acquired Pneumonia.


Lead Product(s): Ceftriaxone,Moxifloxacin,Levofloxacin,Piperacillin + Tazobactam,Ceftaroline Fosamil,Amoxicillin Trihydrate,Clavulanic Acid,Azithromycin,

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Antibiotic

Sponsor: Australian and New Zealand Intensive Care Research Centre | Medical Research Institute of New Zealand | Unity Health | Berry Consultants | Global Coalition for Adaptive Research | University of Pittsburgh Medical Center | Intensive Care National Audit & R

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 13, 2016

blank

03

UMC Utrecht

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

UMC Utrecht

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Lead Product(s) : Ceftriaxone, Moxifloxacin, Levofloxacin, Piperacillin + Tazobactam, Ceftaroline Fosamil

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Australian and New Zealand Intensive Care Research Centre | Medical Research Institute of New Zealand | Unity Health | Berry Consultants | Global Coalition for Adaptive Research | University of Pittsburgh Medical Center | Intensive Care National Audit & R

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Ceftriaxone is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Community-Acquired Pneumonia.

Product Name : Undisclosed

Product Type : Antibiotic

Upfront Cash : Inapplicable

April 13, 2016

blank
  • Development Update

Details:

Daptomycin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Bacteremia.


Lead Product(s): Daptomycin,Ceftaroline Fosamil

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Antibiotic

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 21, 2016

blank

04

Sharp HealthCare

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Sharp HealthCare

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Daptomycin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Bacteremia.

Product Name : Undisclosed

Product Type : Antibiotic

Upfront Cash : Inapplicable

January 21, 2016

blank

Details:

Ceftaroline is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Ceftaroline Fosamil,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Basim Asmar

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 09, 2015

blank

05

Vietnam Medi-Pharm Expo
Not Confirmed
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Ceftaroline is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 09, 2015

blank
  • Development Update

Details:

Ceftaroline is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Skin Diseases, Infectious.


Lead Product(s): Ceftaroline Fosamil,Vancomycin Hydrochloride

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Henry Ford Hospital | St. John Providence Health System | Detroit Medical Center | Forest Laboratories

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 21, 2015

blank

06

Wayne State University

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Wayne State University

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Lead Product(s) : Ceftaroline Fosamil,Vancomycin Hydrochloride

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase IV

Partner/Sponsor/Collaborator : Henry Ford Hospital | St. John Providence Health System | Detroit Medical Center | Forest Laboratories

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Ceftaroline is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Skin Diseases, Infectious.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 21, 2015

blank

Details:

Ceftaroline Fosamil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neonatal Sepsis.


Lead Product(s): Ceftaroline Fosamil,Ampicillin,Aminoglycoside

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: PRA Health Sciences

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 23, 2015

blank

07

Pfizer Inc

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Pfizer Inc

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Ceftaroline Fosamil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neonatal Sepsis.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 23, 2015

blank

Details:

Ceftaroline Fosamil is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Osteomyelitis.


Lead Product(s): Ceftaroline Fosamil,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase I/ Phase IIProduct Type: Miscellaneous

Sponsor: Allergan

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 12, 2015

blank

08

Vietnam Medi-Pharm Expo
Not Confirmed
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Ceftaroline Fosamil is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Osteomyelitis.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 12, 2015

blank
  • Development Update

Details:

Ceftaroline is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Surgical Wound Infection.


Lead Product(s): Ceftaroline Fosamil,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Forest Laboratories

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 03, 2014

blank

09

University of Cincinnati

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

University of Cincinnati

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Ceftaroline is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Surgical Wound Infection.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 03, 2014

blank

Details:

Ceftaroline Fosamil is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Skin Diseases, Infectious.


Lead Product(s): Ceftaroline Fosamil,Inapplicable

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Forest Laboratories

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 28, 2014

blank

10

Pfizer Inc

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Pfizer Inc

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Ceftaroline Fosamil is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Skin Diseases, Infectious.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 28, 2014

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Thickeners and Stabilizers

read-more
read-more

Parenteral

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for / Ceftaroline Fosamil API manufacturers, exporters & distributors?

Ceftaroline Fosamil manufacturers, exporters & distributors 1

12

PharmaCompass offers a list of Ceftaroline Fosamil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ceftaroline Fosamil manufacturer or Ceftaroline Fosamil supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ceftaroline Fosamil manufacturer or Ceftaroline Fosamil supplier.

API | Excipient name

Ceftaroline Fosamil

Synonyms

Tak-599, Schembl1464044, Gtpl10899, Q409712, (6r,7r)-7-((z)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Ceftaroline Manufacturers

A Ceftaroline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ceftaroline, including repackagers and relabelers. The FDA regulates Ceftaroline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ceftaroline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ceftaroline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Ceftaroline Suppliers

A Ceftaroline supplier is an individual or a company that provides Ceftaroline active pharmaceutical ingredient (API) or Ceftaroline finished formulations upon request. The Ceftaroline suppliers may include Ceftaroline API manufacturers, exporters, distributors and traders.

click here to find a list of Ceftaroline suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Ceftaroline USDMF

A Ceftaroline DMF (Drug Master File) is a document detailing the whole manufacturing process of Ceftaroline active pharmaceutical ingredient (API) in detail. Different forms of Ceftaroline DMFs exist exist since differing nations have different regulations, such as Ceftaroline USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Ceftaroline DMF submitted to regulatory agencies in the US is known as a USDMF. Ceftaroline USDMF includes data on Ceftaroline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ceftaroline USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Ceftaroline suppliers with USDMF on PharmaCompass.

Ceftaroline GMP

Ceftaroline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Ceftaroline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ceftaroline GMP manufacturer or Ceftaroline GMP API supplier for your needs.

Ceftaroline CoA

A Ceftaroline CoA (Certificate of Analysis) is a formal document that attests to Ceftaroline's compliance with Ceftaroline specifications and serves as a tool for batch-level quality control.

Ceftaroline CoA mostly includes findings from lab analyses of a specific batch. For each Ceftaroline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Ceftaroline may be tested according to a variety of international standards, such as European Pharmacopoeia (Ceftaroline EP), Ceftaroline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ceftaroline USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty